Prostate Cancer
Conditions
Brief summary
The role of PET/CT with Choline in the restaging of prostatic disease is now universally recognized, and its use has become routine in numerous centers in Italy and abroad. The indication for the test is provided exclusively by an increase in PSA. It was interesting to understand whether these prognostic factors have an influence on the probability of detecting disease by PET with Choline to identify patients who have a greater probability of benefiting from the use of this method with the possibility of identifying the disease in earlier stages.
Interventions
DIAGNOSTIC_TESTDiagnostic accuracy
The aim of the study is to evaluate whether the pathological stage of the disease, Gleason score, age at diagnosis, serum PSA value and PET parameters (SUV, MTV) are predictive factors of choline PET examination.
Sponsors
IRCCS San Raffaele
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Inclusion criteria
* patients operated with radical prostatectomy * patients that present biochemical recurrence of the disease;
Exclusion criteria
* patients \<18 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PET/CT with Choline in the restaging of prostatic disease. | 1 year | retrospective analysis of 68 patients with biochemical recurrence of prostase disease that performed PET/CT with choline for the restaging of the disease. |
Countries
Italy
Outcome results
None listed